Table 7.
Molecular Feature | Target of Therapies | Drug(s) |
---|---|---|
VEGFR-2 | VEGFR-2 + cells | Regorafenib, Nivolumab. Cabozantinib, Ramucirumab |
MAPK pathway | MAPK | Sorafenib, Lenvatinib |
Abbreviations: MAPK, mitogen-activated protein kinase; VEGFR, vascular endothelial growth factor receptor.